- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Castration-resistant Prostate Cancer in Colombia
Total 614 results
-
British Columbia Cancer AgencyUniversity of British Columbia; Vancouver Prostate Centre; BC Cancer FoundationRecruitingLocalized Prostate CarcinomaCanada
-
National Human Genome Research Institute (NHGRI)Completed
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); North Central Cancer Treatment GroupCompletedPain | Breast Cancer | Prostate Cancer | Metastatic CancerUnited States, Canada
-
Canadian Urology Research ConsortiumFerring PharmaceuticalsTerminated
-
British Columbia Cancer AgencyRecruitingProstate CancerCanada
-
University of Missouri-ColumbiaWithdrawnProstate CancerUnited States
-
British Columbia Cancer AgencyUnknown
-
University of British ColumbiaUnited States Department of DefenseCompleted
-
Vancouver Coastal HealthLotte & John Hecht Memorial FoundationTerminated
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); British Columbia Innovation...Completed
-
University of British ColumbiaUnknownProstate CancerCanada
-
Georgetown UniversityCompletedPhysical Activity | Metabolic Syndrome | Prostate CancerUnited States
-
University of South CarolinaUnited States Department of DefenseCompleted
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerKorea, Republic of, Japan, United States, Argentina, Australia, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, United...
-
BayerOrion Corporation, Orion PharmaCompletedMetastatic Hormone-sensitive Prostate CancerBelgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
-
Vancouver Prostate CentreCompletedSexual Dysfunction | Prostate CancerCanada
-
British Columbia Cancer AgencyActive, not recruitingNeoplasms | Urogenital Neoplasms | Disease Attributes | Prostate Cancer | Prostatic Neoplasm | Prostatic DiseaseCanada
-
University Health Network, TorontoCompleted
-
Georgetown UniversityNational Cancer Institute (NCI); United States Department of DefenseCompleted
-
Georgetown UniversityNational Cancer Institute (NCI)Completed
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
INSYS Therapeutics IncWithdrawnProstate CancerUnited States
-
University Health Network, TorontoMcGill University Health Centre/Research Institute of the McGill University... and other collaboratorsCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Completed
-
British Columbia Cancer AgencyAstraZenecaCompleted
-
Canadian Urology Research ConsortiumProstate Cancer Canada; Ontario Institute for Cancer ResearchUnknown
-
Centers for Disease Control and PreventionThe University of Texas Health Science Center, HoustonCompletedProstate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)SuspendedProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8Canada, United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedProstate CancerUnited States
-
British Columbia Cancer AgencyThe Prostate Centre - Vancouver Island and the Gulf IslandsWithdrawn
-
University of British ColumbiaCanadian Cancer Society (CCS)CompletedProstate CancerCanada
-
University of Michigan Rogel Cancer CenterNovartis PharmaceuticalsTerminatedProstate CancerUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
Georgetown UniversityAmerican Cancer Society, Inc.CompletedPhysical Activity | Prostate Cancer | Side-effectsUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia...CompletedProstate CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
James AhlgrenWithdrawnProstate CancerUnited States
-
Alberta Health servicesPfizerUnknown
-
RPCR, Inc.UnknownProstate Cancer Early Risk Treated by Radiosurgery | Prostate Cancer Intermediate Risk Treated by RadiosurgeryUnited States
-
M.D. Anderson Cancer CenterCompletedProstate CancerUnited States, Canada
-
British Columbia Cancer AgencyCompleted
-
CMX ResearchPeptigroupe Inc.CompletedProstate CancerCanada, Georgia
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerCanada, United States
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedProstate CancerCanada
-
NCIC Clinical Trials GroupCompleted